1111 related articles for article (PubMed ID: 26375006)
21. Chemically modified guide RNAs enhance CRISPR-Cas genome editing in human primary cells.
Hendel A; Bak RO; Clark JT; Kennedy AB; Ryan DE; Roy S; Steinfeld I; Lunstad BD; Kaiser RJ; Wilkens AB; Bacchetta R; Tsalenko A; Dellinger D; Bruhn L; Porteus MH
Nat Biotechnol; 2015 Sep; 33(9):985-989. PubMed ID: 26121415
[TBL] [Abstract][Full Text] [Related]
22. Programmable RNA recognition and cleavage by CRISPR/Cas9.
O'Connell MR; Oakes BL; Sternberg SH; East-Seletsky A; Kaplan M; Doudna JA
Nature; 2014 Dec; 516(7530):263-6. PubMed ID: 25274302
[TBL] [Abstract][Full Text] [Related]
23. Enhancement of single guide RNA transcription for efficient CRISPR/Cas-based genomic engineering.
Ui-Tei K; Maruyama S; Nakano Y
Genome; 2017 Jun; 60(6):537-545. PubMed ID: 28177825
[TBL] [Abstract][Full Text] [Related]
24. New vectors for simple and streamlined CRISPR-Cas9 genome editing in Saccharomyces cerevisiae.
Laughery MF; Hunter T; Brown A; Hoopes J; Ostbye T; Shumaker T; Wyrick JJ
Yeast; 2015 Dec; 32(12):711-20. PubMed ID: 26305040
[TBL] [Abstract][Full Text] [Related]
25. CRISPR GUARD protects off-target sites from Cas9 nuclease activity using short guide RNAs.
Coelho MA; De Braekeleer E; Firth M; Bista M; Lukasiak S; Cuomo ME; Taylor BJM
Nat Commun; 2020 Aug; 11(1):4132. PubMed ID: 32807781
[TBL] [Abstract][Full Text] [Related]
26. An Agrobacterium-delivered CRISPR/Cas9 system for high-frequency targeted mutagenesis in maize.
Char SN; Neelakandan AK; Nahampun H; Frame B; Main M; Spalding MH; Becraft PW; Meyers BC; Walbot V; Wang K; Yang B
Plant Biotechnol J; 2017 Feb; 15(2):257-268. PubMed ID: 27510362
[TBL] [Abstract][Full Text] [Related]
27. In Vivo Genome Editing Restores Dystrophin Expression and Cardiac Function in Dystrophic Mice.
El Refaey M; Xu L; Gao Y; Canan BD; Adesanya TMA; Warner SC; Akagi K; Symer DE; Mohler PJ; Ma J; Janssen PML; Han R
Circ Res; 2017 Sep; 121(8):923-929. PubMed ID: 28790199
[TBL] [Abstract][Full Text] [Related]
28. Developing Heritable Mutations in Arabidopsis thaliana Using a Modified CRISPR/Cas9 Toolkit Comprising PAM-Altered Cas9 Variants and gRNAs.
Yamamoto A; Ishida T; Yoshimura M; Kimura Y; Sawa S
Plant Cell Physiol; 2019 Oct; 60(10):2255-2262. PubMed ID: 31198958
[TBL] [Abstract][Full Text] [Related]
29. All-in-One CRISPR-Cas9/FokI-dCas9 Vector-Mediated Multiplex Genome Engineering in Cultured Cells.
Sakuma T; Sakamoto T; Yamamoto T
Methods Mol Biol; 2017; 1498():41-56. PubMed ID: 27709568
[TBL] [Abstract][Full Text] [Related]
30. CRISPR/Cas9 system as an innovative genetic engineering tool: Enhancements in sequence specificity and delivery methods.
Jo YI; Suresh B; Kim H; Ramakrishna S
Biochim Biophys Acta; 2015 Dec; 1856(2):234-43. PubMed ID: 26434948
[TBL] [Abstract][Full Text] [Related]
31. Postnatal Cardiac Gene Editing Using CRISPR/Cas9 With AAV9-Mediated Delivery of Short Guide RNAs Results in Mosaic Gene Disruption.
Johansen AK; Molenaar B; Versteeg D; Leitoguinho AR; Demkes C; Spanjaard B; de Ruiter H; Akbari Moqadam F; Kooijman L; Zentilin L; Giacca M; van Rooij E
Circ Res; 2017 Oct; 121(10):1168-1181. PubMed ID: 28851809
[TBL] [Abstract][Full Text] [Related]
32. P53 ICE CRIM mouse: a tool to generate mutant allelic series in somatic cells and germ lines for cancer studies.
Fan HH; Yu IS; Lin YH; Wang SY; Liaw YH; Chen PL; Yang TL; Lin SW; Chen YT
FASEB J; 2019 Apr; 33(4):5571-5584. PubMed ID: 30640520
[TBL] [Abstract][Full Text] [Related]
33. Genome-wide recessive genetic screening in mammalian cells with a lentiviral CRISPR-guide RNA library.
Koike-Yusa H; Li Y; Tan EP; Velasco-Herrera Mdel C; Yusa K
Nat Biotechnol; 2014 Mar; 32(3):267-73. PubMed ID: 24535568
[TBL] [Abstract][Full Text] [Related]
34. Interrogation of enhancer function by enhancer-targeting CRISPR epigenetic editing.
Li K; Liu Y; Cao H; Zhang Y; Gu Z; Liu X; Yu A; Kaphle P; Dickerson KE; Ni M; Xu J
Nat Commun; 2020 Jan; 11(1):485. PubMed ID: 31980609
[TBL] [Abstract][Full Text] [Related]
35. Detection of Multiple Genome Modifications Induced by the CRISPR/Cas9 System.
Ota S; Kawahara A
Methods Mol Biol; 2016; 1451():53-63. PubMed ID: 27464800
[TBL] [Abstract][Full Text] [Related]
36. Transgene-free genome editing by germline injection of CRISPR/Cas RNA.
Schwartz HT; Sternberg PW
Methods Enzymol; 2014; 546():441-57. PubMed ID: 25398352
[TBL] [Abstract][Full Text] [Related]
37. Multigene knockout utilizing off-target mutations of the CRISPR/Cas9 system in rice.
Endo M; Mikami M; Toki S
Plant Cell Physiol; 2015 Jan; 56(1):41-7. PubMed ID: 25392068
[TBL] [Abstract][Full Text] [Related]
38. In vivo blunt-end cloning through CRISPR/Cas9-facilitated non-homologous end-joining.
Geisinger JM; Turan S; Hernandez S; Spector LP; Calos MP
Nucleic Acids Res; 2016 May; 44(8):e76. PubMed ID: 26762978
[TBL] [Abstract][Full Text] [Related]
39. Dissecting Tissue-Specific Super-Enhancers by Integrating Genome-Wide Analyses and CRISPR/Cas9 Genome Editing.
Yoo KH; Hennighausen L; Shin HY
J Mammary Gland Biol Neoplasia; 2019 Mar; 24(1):47-59. PubMed ID: 30291498
[TBL] [Abstract][Full Text] [Related]
40. 5S rRNA Promoter for Guide RNA Expression Enabled Highly Efficient CRISPR/Cas9 Genome Editing in
Zheng X; Zheng P; Zhang K; Cairns TC; Meyer V; Sun J; Ma Y
ACS Synth Biol; 2019 Jul; 8(7):1568-1574. PubMed ID: 29687998
[TBL] [Abstract][Full Text] [Related]
[Previous] [Next] [New Search]
